Wanhong Lu1, Wing-Fai Pang2, Li Jin1, Huixian Li1, Kai Ming Chow2, Bonnie Ching-Ha Kwan2, Chi Bon Leung2, Philip Kam-Tao Li2, Cheuk Chun Szeto3. 1. Nephrology Department, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China. 2. Department of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. 3. Department of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. ccszeto@cuhk.edu.hk.
Abstract
BACKGROUND: Peritoneal protein clearance has been suggested to be a marker of peritoneal inflammation and systemic endothelial dysfunction. METHODS: We enrolled 711 consecutive incident PD patients. Baseline peritoneal protein clearance and other clinical information were reviewed. All patients were followed for at least 1 year for all-cause and cardiovascular mortality. RESULTS: The average PD effluent protein loss was 6.41 ± 2.16 g/day; peritoneal protein clearance was 97.15 ± 41.55 mL/day. The average duration of follow-up was 50.8 ± 36.2 months. Multivariate linear regression analysis showed that serum albumin, C-reactive protein, and mass transfer area coefficients of creatinine were independently associated with peritoneal protein clearance. By multivariate Cox regression analysis, age, Charlson comorbidity score, volume of overhydration and peritoneal protein clearance were independent predictors of all-cause mortality. Every 10 mL/day increase in peritoneal protein clearance confers 10.4% increase in risk of all-cause mortality (95% confidence interval 2.6-18.7%, p = 0.008). Peritoneal protein clearance was also associated with cardiovascular mortality by univariate analysis, but the association became insignificant after adjusting for confounding factors Cox regression analysis. CONCLUSIONS: Baseline peritoneal protein clearance is an independent predictor of all-cause mortality in incident PD patients. Routine measurement of peritoneal protein clearance may facilitate patient risk stratification.
BACKGROUND: Peritoneal protein clearance has been suggested to be a marker of peritoneal inflammation and systemic endothelial dysfunction. METHODS: We enrolled 711 consecutive incident PDpatients. Baseline peritoneal protein clearance and other clinical information were reviewed. All patients were followed for at least 1 year for all-cause and cardiovascular mortality. RESULTS: The average PD effluent protein loss was 6.41 ± 2.16 g/day; peritoneal protein clearance was 97.15 ± 41.55 mL/day. The average duration of follow-up was 50.8 ± 36.2 months. Multivariate linear regression analysis showed that serum albumin, C-reactive protein, and mass transfer area coefficients of creatinine were independently associated with peritoneal protein clearance. By multivariate Cox regression analysis, age, Charlson comorbidity score, volume of overhydration and peritoneal protein clearance were independent predictors of all-cause mortality. Every 10 mL/day increase in peritoneal protein clearance confers 10.4% increase in risk of all-cause mortality (95% confidence interval 2.6-18.7%, p = 0.008). Peritoneal protein clearance was also associated with cardiovascular mortality by univariate analysis, but the association became insignificant after adjusting for confounding factors Cox regression analysis. CONCLUSIONS: Baseline peritoneal protein clearance is an independent predictor of all-cause mortality in incident PDpatients. Routine measurement of peritoneal protein clearance may facilitate patient risk stratification.
Authors: Anabela Malho Guedes; Roberto Calças Marques; Brigitte Ribeiro; Mónica T Fernandes; Marília Faísca; Ana Paula Silva; José Bragança; Anabela Rodrigues Journal: Front Med (Lausanne) Date: 2022-05-26
Authors: Naya Huang; Huiyan Li; Li Fan; Qian Zhou; Dongying Fu; Lin Guo; Chunyan Yi; Xueqing Yu; Haiping Mao Journal: Front Med (Lausanne) Date: 2021-12-01